Clinical Trials Logo
  1. Home
  2. Gallbladder Diseases
  3. NCT04563260
  4. Details
NCT04563260 Clinical Trial

Effect of Palonosetron on Remifentanil for Preventing Emergence Cough in Female

Gallbladder Diseases Clinical Trial

Official title:
Effect of Palonosetron on Effect-site Concentration of Remifentanil for Preventing Emergence Cough During General Anesthesia in Female Patients Undergoing Laparoscopic Cholecystectomy

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04563260
Other study ID # AJIRB-MED-THE-20-174
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 7, 2020
Est. completion date March 19, 2021

Study information
Verified date May 2021
Source Ajou University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary purpose of this study is to investigate the optimal Ce of remifentanil for preventing emergence cough following extubation during general anesthesia in female patients who receive the palonosetron or not.

Description:

Remifentanil is a potent ultrashort-acting opioid, with rapid onset and offset of drug effect. It allows rapid anesthetic emergence even after a prolonged infusion, and decreases the at-risk time during extubation. In addition, cough suppression of remifentanil enables smooth extubation with reduced complications. However, the infusion of remifentanil suppresses the emergence cough effectively in clinical practice, whereas it still delays the awakening from anesthesia, resulting in prolonged emergence time. Reduced Ce of remifentanil during emergence would decrease the adverse events that are associated with remifentanil infusion.

Recruitment information / eligibility
Status Completed
Enrollment 45
Est. completion date March 19, 2021
Est. primary completion date March 19, 2021
Accepts healthy volunteers No
Gender Female
Age group 19 Years to 85 Years
Eligibility Inclusion Criteria: - Laparoscopic cholecystectomy under general anesthesia Exclusion Criteria: - BMI > 30 kg/m2, respiratory infection, uncontrolled hypertension

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Normal saline injection
Normal saline 2 mL, intravenous injection
• Palonosetron Injection [Aloxi]
Palonosetron 1.5 mL (0.075 mg) + Normal saline 0.5 mL, intravenous injection

Locations
Country Name City State
Korea, Republic of Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine Suwon

Sponsors (1)
Lead Sponsor Collaborator
Ajou University School of Medicine

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary optimal Ce of remifentanil Using Dixon methods, evaluating of optimal Ce of remifentanil for preventing emergence cough following extubation during general anesthesia From the end of surgery until the time of endotracheal extubation, about 20 minutes
See also
  Status Clinical Trial Phase
Completed NCT00370344 - Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease Phase 2/Phase 3
Recruiting NCT05900037 - GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery N/A
Withdrawn NCT02827097 - The Effect of Rectus Sheath Block on the Postoperative Analgesia in the Patients Undergoing Robotic Single Port Cholecystectomy N/A
Completed NCT03327688 - Point-of-care Ultrasound in Finland N/A
Completed NCT00388830 - Emergency Ultrasound of the Gallbladder N/A
Completed NCT03583021 - Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Male N/A
Completed NCT02956252 - Spinal Versus General Anesthesia for Laparoscopic Cholecystectomy N/A
Completed NCT00552162 - NOTES Transvaginal Cholecystectomy and Appendectomy N/A
Completed NCT04409652 - Head Position on Preventing Emergence Cough N/A
Recruiting NCT04324515 - Randomized Trial Comparing Gastric Bypass With and Without Cholecystectomy N/A
Recruiting NCT04915651 - Gallbladder Cryoablation in High-Risk Patients N/A
Completed NCT01413633 - A Novel Technique For Gall Bladder Fundus Retraction In Single Incision Laparoscopic Cholecystectomy N/A
Terminated NCT00040131 - Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED) Phase 2
Completed NCT02827136 - Effect of Lidocaine Patch for Shoulder Pain in Laparoscopic Cholecystectomy N/A
Completed NCT06244589 - Evaluation of Risk Factors Leading to Conversion From Laparoscopic Cholecystectomy to Open Surgery N/A
Completed NCT03888976 - Cholecystoduodenal Fistula With and Without Gallstone Ileus
Withdrawn NCT03160157 - Comparing the Outcomes of Laparoscopic Cholecystectomy vs. Robotic Cholecystectomy
Completed NCT04407078 - Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Female N/A
Not yet recruiting NCT04922528 - Visualization of the Extrahepatic biliaRy Tree Trial N/A
Not yet recruiting NCT06315179 - Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)